We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Katharine
Bowker
-
snap2@nottingham.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Adherence to nicotine replacement therapy during pregnancy
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Nicotine replacement therapy (NRT) helps non pregnant smokers to stop smoking. However, during pregnancy adherence is often low, for example the duration women take it and/or the amount taken is often not enough. Poor adherence reduces pregnant women’s chances of stopping smoking.
We have created an intervention called ‘Baby, Me & NRT’ (BMN) to help improve adherence to NRT during pregnancy which emphasises the use of NRT for longer and in more adequate doses. BMN will run alongside usual NHS smoking cessation care. The intervention includes reinforcement of key NRT adherence-enhancing messages via a leaflet and a website. It also includes personally tailored SMS text messages which support abstinence, encourage NRT use to control withdrawal symptoms and/or cravings, counters concern about nicotine and so intentional non-adherence and minimise forgetting NRT through prompts and reminders.
The aim of this study is to test whether the BMN intervention improves pregnant women’s adherence to NRT and quit rates during pregnancy.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2024 Protocol article in https://doi.org/10.1136/bmjopen-2024-087175 (added 29/05/2024)
You can take part if:
Current inclusion criteria as of 12/01/2022:
1. Pregnant (<25 weeks’ gestation)
2. Aged 16 years or over
3. Having been referred for or having received any kind of appointment as part of standard available antenatal care
4. Smoked 5 or more cigarettes per day pre-pregnancy and currently smoking at least 1 cigarette daily
5. Motivated to quit smoking, wants to try NRT and willing to set a quit date within 14 days
6. Agrees to accept the intervention or control, and to participate in study data collection
7. Owns a smartphone, uses it for sending and receiving SMS text messages, and agrees to install both the trial’s ‘NicUse’ app (collects data on smoking and NRT use) and an app for transferring exhaled carbon monoxide (CO) readings to study team
8. Understands written and spoken English
9. Able to
You may not be able to take part if:
1. Already enrolled in a smoking cessation study or NHS stop smoking support2. Already enrolled in another text service to assist smoking cessation3. Using an e-cigarette/vaping device and/or a heat not burn product, and not willing to stop using this to join the study 4. Already using NRT to quit or cut down smoking5. Contraindications to NRT including: severe cardiovascular disease, unstable angina, cardiac arrhythmias, recent cerebrovascular accident or TIA, chronic, generalized skin disorders or sensitivity to nicotine patches, chemical dependence / alcohol addiction; major fetal anomalies
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Katharine
Bowker
-
snap2@nottingham.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Nottingham and funded by NIHR Central Commissioning Facility (CCF); Grant Codes: RP-PG-0615-20003; National Institute for Health Research (NIHR) (UK).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 48261
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
